BioMarin Pharmaceutical
BMRN
#1746
Rank
C$17.05 B
Marketcap
C$88.07
Share price
-0.02%
Change (1 day)
19.81%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2026 (TTM): C$58.74 Million

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are C$3.65 Billion. In 2025 the company made an earning of C$0.69 Billion a decrease over its 2024 earnings that were of C$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$58.74 M-91.51%
2025 C$0.69 B-10.94%
2024 C$0.77 B187.31%
2023 C$0.27 B26.07%
2022 C$0.21 B-298.51%
2021 -C$0.11 Billion78.04%
2020 -C$60.69 Million-55.36%
2019 -C$0.14 Billion-33.56%
2018 -C$0.21 Billion297.78%
2017 -C$51.44 Million-95.68%
2016 -C$1.2 Billion437.12%
2015 -C$0.23 Billion23.91%
2014 -C$0.18 Billion-29.25%
2013 -C$0.26 Billion49.23%
2012 -C$0.17 Billion171.11%
2011 -C$62.56 Million103.01%
2010 -C$30.82 Million-3903.54%
2009 C$0.81 M-98.31%
2008 C$47.92 M-189.7%
2007 -C$53.43 Million51.02%
2006 -C$35.38 Million-61.58%
2005 -C$92.08 Million-56.59%
2004 -C$0.22 Billion95.13%
2003 -C$0.11 Billion12.09%
2002 -C$96.97 Million73.19%
2001 -C$55.99 Million18.32%
2000 -C$47.32 Million19.65%
1999 -C$39.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
C$11.16 B 17,735.86%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-C$0.65 Billion-1,124.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-C$0.16 Billion-352.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$0.11 B 81.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$0.27 M-99.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$0.42 B 578.94%๐Ÿ‡บ๐Ÿ‡ธ USA